Chang'an Capital

Total investments

17

Average round size

12M

Portfolio companies

15

Lead investments

2

Follow on index

0.12

Exits

1

Stages of investment
Early Stage Venture
Areas of investment
AutomotiveBiotechnologyInternetBig DataRoboticsNetwork SecurityMedicalTherapeuticsHardwareTechnical Support

Investments analytics

Analytics

Total investments
17
Lead investments
2
Exits
1
Follow on index
0.12
Investments by industry
  • Biotechnology (5)
  • Internet (4)
  • Therapeutics (3)
  • Hardware (2)
  • Automotive (2)
  • Show 31 more
Investments by region
  • China (17)
Peak activity year
2015

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
8
Group Appearance index
0.82

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
ProfoundBio 12 Jul 2021 Biotechnology, Therapeutics Early Stage Venture 55M Jiangsu, Suzhou, China
Sequana Medical 23 Oct 2015 Biotechnology, Health Care, Manufacturing, Medical Device Late Stage Venture 9M Switzerland, Zurich, Zurich
Spatomics 09 Aug 2023 Biotechnology, Health Care, Medical Seed Jiangsu, Suzhou, China
SpoonJoy 29 Dec 2014 Food and Beverage, Mobile Apps, Hospitality, Subscription Service, Food Delivery Seed 36K Bangalore, Karnataka, India

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.